ETF Education Report: BIOY

What this ETF is trying to do

The YIELDMAX(R) TARGET 12(TM) BIOTECH & PHARMA OPTION INCOME ETF (ticker: BIOY) is an exchange-traded fund (ETF) listed on the NASDAQ. This specific type of fund is categorized as an "option income" ETF. These funds often use different financial tools to try and create regular cash payments for investors.

What the numbers show

As of September 22, 2026, the current price of one share of BIOY is $20.62.

It is important to note that many performance figures were not supplied in the current data. We do not have information regarding the year-to-date price return, the one-year price return, or the three-year price return. Because these numbers are not available, we cannot say how much the share price has changed over those time periods. Additionally, total-return data was not supplied.

Income and distribution explanation

One of the main features of this ETF is its distributions, which are the cash payments made to shareholders.

• Distribution Yield: The distribution yield is approximately 25.02%. This number describes the cash payments relative to the current ETF price.

• Payout Frequency: The fund usually pays out monthly. In the last 12 months, there were 20 distributions.

• Timing: Most of these payments have occurred on Fridays.

It is very important for new investors to understand that a high distribution yield is not the same thing as a "total return." A high yield means the fund is paying out a lot of cash, but it does not tell you if the actual value of your investment is growing or shrinking.

NAV erosion explanation

"NAV erosion" is a term used to describe when the Net Asset Value (the actual value of the assets held by the fund) decreases over time. While some investors worry about erosion when they see high payouts, there is no severe erosion-risk flag for this ETF. However, the data provided does not include an erosion score because there is insufficient verified price history available to calculate one.

Pros

• The fund provides a high distribution yield of approximately 25.02%.

• It offers frequent cash payments, with 20 distributions recorded over the last year.

Cons

• There is no supplied data regarding price returns or total returns to show how the fund has performed historically.

• There is no information available regarding the fund's top holdings or what specific companies it owns.

Beginner takeaway

When looking at an ETF like BIOY, a high distribution yield can be very eye-catching. However, high yields alone can be misleading. Investors should always look at the "total return"—which includes both price changes and cash payments—to get a full picture. Because the performance data for this ETF was not supplied, it is impossible to determine how the share price has behaved in the past.